Home

klein Durch Wiederholt overall survival Lautsprecher Kind Buchhandlung

Overall survival results of AGO-OVAR16: A phase 3 study of maintenance  pazopanib versus placebo in women who have not progressed after first-line  chemotherapy for advanced ovarian cancer - Gynecologic Oncology
Overall survival results of AGO-OVAR16: A phase 3 study of maintenance pazopanib versus placebo in women who have not progressed after first-line chemotherapy for advanced ovarian cancer - Gynecologic Oncology

PLOS ONE: Significant predictors of overall survival in patients with  hepatocellular carcinoma after surgical resection
PLOS ONE: Significant predictors of overall survival in patients with hepatocellular carcinoma after surgical resection

ADMIRAL Trial: XOSPATA® (gilteritinib) Overall Survival
ADMIRAL Trial: XOSPATA® (gilteritinib) Overall Survival

Survival with Olaparib in Metastatic Castration-Resistant Prostate Cancer |  NEJM
Survival with Olaparib in Metastatic Castration-Resistant Prostate Cancer | NEJM

A prognostic nomogram for overall survival in male breast cancer with  histology of infiltrating duct carcinoma after surgery [PeerJ]
A prognostic nomogram for overall survival in male breast cancer with histology of infiltrating duct carcinoma after surgery [PeerJ]

Fig. 3, [Kaplan-Meier curves showing overall survival...]. - Brain and  Human Body Modeling 2020 - NCBI Bookshelf
Fig. 3, [Kaplan-Meier curves showing overall survival...]. - Brain and Human Body Modeling 2020 - NCBI Bookshelf

The development and external validation of an overall survival nomogram in  medically inoperable centrally located early-stage non-small cell lung  carcinoma - Radiotherapy and Oncology
The development and external validation of an overall survival nomogram in medically inoperable centrally located early-stage non-small cell lung carcinoma - Radiotherapy and Oncology

Long-term follow-up of overall survival for cabozantinib versus everolimus  in advanced renal cell carcinoma | British Journal of Cancer
Long-term follow-up of overall survival for cabozantinib versus everolimus in advanced renal cell carcinoma | British Journal of Cancer

A prognostic model for overall survival of patients with early-stage  non-small cell lung cancer: a multicentre, retrospective study - The Lancet  Digital Health
A prognostic model for overall survival of patients with early-stage non-small cell lung cancer: a multicentre, retrospective study - The Lancet Digital Health

Overall survival for oncology drugs approved for genomic indications -  European Journal of Cancer
Overall survival for oncology drugs approved for genomic indications - European Journal of Cancer

Improved Overall Survival With Comprehensive Local Consolidative Therapy in  Synchronous Oligometastatic Non–Small-Cell Lung Cancer - Clinical Lung  Cancer
Improved Overall Survival With Comprehensive Local Consolidative Therapy in Synchronous Oligometastatic Non–Small-Cell Lung Cancer - Clinical Lung Cancer

Real-World Overall Survival | IBRANCE® (palbociclib) | Safety Info
Real-World Overall Survival | IBRANCE® (palbociclib) | Safety Info

Overall Survival Data | ABRAXANE (paclitaxel protein-bound particles for  injectable suspension) (albumin-bound)
Overall Survival Data | ABRAXANE (paclitaxel protein-bound particles for injectable suspension) (albumin-bound)

Sirtex - Overall Survival
Sirtex - Overall Survival

IMFINZI® (durvalumab) Efficacy & Clinical Trials for ES-SCLC
IMFINZI® (durvalumab) Efficacy & Clinical Trials for ES-SCLC

Extrapulmonary small cell carcinoma: Prognostic factors, patterns of care,  and overall survival - European Journal of Surgical Oncology
Extrapulmonary small cell carcinoma: Prognostic factors, patterns of care, and overall survival - European Journal of Surgical Oncology

Predictors of progression free survival, overall survival and early  cessation of chemotherapy in women with potentially platinum sensitive  (PPS) recurrent ovarian cancer (ROC) starting third or subsequent line(≥3)  chemotherapy – The GCIG
Predictors of progression free survival, overall survival and early cessation of chemotherapy in women with potentially platinum sensitive (PPS) recurrent ovarian cancer (ROC) starting third or subsequent line(≥3) chemotherapy – The GCIG

Checkpoint inhibitor immunotherapy toxicity and overall survival among  older adults with advanced cancer - Journal of Geriatric Oncology
Checkpoint inhibitor immunotherapy toxicity and overall survival among older adults with advanced cancer - Journal of Geriatric Oncology

Cureus | Analysis of Overall Survival in Patients With Multiple Primary  Malignancies: A Single-center Experience
Cureus | Analysis of Overall Survival in Patients With Multiple Primary Malignancies: A Single-center Experience

JCI Insight - Mutational analysis of head and neck squamous cell carcinoma  stratified by smoking status
JCI Insight - Mutational analysis of head and neck squamous cell carcinoma stratified by smoking status

TERT promoter mutations are associated with longer progression-free and overall  survival in patients with BRAF-mutant melanoma receiving BRAF and MEK  inhibitor therapy - European Journal of Cancer
TERT promoter mutations are associated with longer progression-free and overall survival in patients with BRAF-mutant melanoma receiving BRAF and MEK inhibitor therapy - European Journal of Cancer

Final overall survival results from a randomised, phase III study of  erlotinib versus chemotherapy as first-line treatment of EGFR  mutation-positive advanced non-small-cell lung cancer (OPTIMAL, CTONG-0802)  - Annals of Oncology
Final overall survival results from a randomised, phase III study of erlotinib versus chemotherapy as first-line treatment of EGFR mutation-positive advanced non-small-cell lung cancer (OPTIMAL, CTONG-0802) - Annals of Oncology

Sirtex - Overall Survival
Sirtex - Overall Survival

Overall survival and cancer-specific survival in patients with surgically  resected pancreatic head adenocarcinoma: A competing risk nomogram analysis
Overall survival and cancer-specific survival in patients with surgically resected pancreatic head adenocarcinoma: A competing risk nomogram analysis

Overall survival. The Kaplan-Meier graph shows overall survival of the... |  Download Scientific Diagram
Overall survival. The Kaplan-Meier graph shows overall survival of the... | Download Scientific Diagram

Circulating inflammation signature predicts overall survival and  relapse-free survival in metastatic colorectal cancer | British Journal of  Cancer
Circulating inflammation signature predicts overall survival and relapse-free survival in metastatic colorectal cancer | British Journal of Cancer

Three-Year Overall Survival with Durvalumab after Chemoradiotherapy in  Stage III NSCLC—Update from PACIFIC - Journal of Thoracic Oncology
Three-Year Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC—Update from PACIFIC - Journal of Thoracic Oncology